DEF: Alumis Inc. Schedules 2026 Annual Meeting

Alumis Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 30, 2026, to elect directors and ratify auditor appointment.

Summary

• Alumis Inc. is holding its 2026 Annual Meeting of Stockholders virtually on June 30, 2026, at 9:00 a.m. Pacific Time.
• The meeting's agenda includes the election of three Class II directors, ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026, and any other business properly brought before the meeting.
• Stockholders of record as of May 5, 2026, are entitled to vote.
• Proxy materials will be made available online on or about May 18, 2026.
• The company encourages stockholders to vote in advance via internet, telephone, or mail.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine proxy statement for an annual meeting with no new financial or strategic information beyond procedural matters.

Positives

• The company is holding its annual meeting to ensure shareholder engagement and governance.
• The virtual format aims to provide a consistent and accessible experience for all stockholders.
• The company is providing multiple methods for stockholders to vote, including online, telephone, and mail.
• The board recommends voting in favor of all director nominees and the ratification of the independent auditor.

Risks

• Brokers may not be able to vote uninstructed shares for the election of directors (Proposal 1) as it is considered a non-routine matter.
• If a quorum is not met, the meeting may be adjourned, potentially delaying important corporate decisions.

Future Outlook

The filing does not contain specific forward-looking financial guidance but outlines the agenda for the upcoming annual meeting, which includes standard corporate governance matters.

Management Comments

• "Your vote is important. Whether or not you expect to attend the Annual Meeting, please vote as promptly as possible to ensure your representation at the Annual Meeting."
• "We believe this expands stockholder access, improves communications and lowers our costs while reducing the environmental impact of the meeting."

Industry Context

StockSavvy.ai notes that Alumis Inc.'s proxy statement is a standard procedural document for a publicly traded company, outlining the annual meeting agenda, director nominations, and auditor ratification, which are common practices in the biotechnology and pharmaceutical sectors.

Corporate Governance

Related Party Transactions

• Entities affiliated with Foresite Capital Management and Samsara BioCapital, LP participated in a public offering on January 7, 2026, purchasing shares on the same terms as other investors. James B. Tananbaum, M.D. is affiliated with Foresite Capital Management, and Srinivas Akkaraju, M.D., Ph.D. is affiliated with Samsara BioCapital, LP.
• Voting and support agreements were entered into on February 6, 2025, by entities affiliated with Foresite Capital Management, AyurMaya Capital Management Fund, LP, Samsara BioCapital, LP, and Martin Babler, collectively holding approximately 62% of outstanding stock, to vote in favor of a merger with ACELYRIN, Inc. Alan Colowick, M.D., M.P.H. is affiliated with AyurMaya Capital Management Fund LP.
• Foresite Labs, LLC, affiliated with Foresite Capital Management, provides data and analytics services and scientific support under a services agreement. Expenses recognized were $1.1 million for 2025 and $0.9 million for 2024.
• Several entities affiliated with major stockholders and directors (AyurMaya Capital Management Fund, LP, entities affiliated with Baker Brothers Life Sciences, L.P., entities affiliated with Foresite Capital Management, Samsara BioCapital, LP, and venBio Global Strategic Fund IV, L.P.) purchased Series C and Series C-1 convertible preferred stock in March and May 2024.

Stakeholder Impact

• Shareholders: The election of directors and ratification of the auditor are key governance matters that impact shareholder rights and company oversight. The virtual meeting format aims to increase accessibility for shareholders.
• Management and Employees: The proxy statement details executive and director compensation, including stock options and potential severance benefits, which can influence employee motivation and retention.
• Auditors: The ratification of PricewaterhouseCoopers LLP as the independent auditor ensures continued financial scrutiny and reporting integrity.

Next Steps

• Stockholders to vote on director nominees and auditor ratification.
• Final voting results to be published in a Form 8-K filing within four business days after the Annual Meeting.

Key Dates

Recommendation

This filing is a routine proxy statement for an annual meeting and does not contain new financial results, strategic updates, or material information that would warrant a change in investment recommendation. It focuses on governance matters such as director elections and auditor ratification.

Keywords

Alumis Inc., Annual Meeting, Proxy Statement, Director Election, Independent Auditor, Stockholder Vote, Corporate Governance, Virtual Meeting